Expanding global access to radiotherapy

The Lancet Oncology

Volumn 16, Issue 10, 2015, Pages 1153-1186

  Atun, Rifat ^a   Jaffray, David A ^d,e,f   Barton, Michael B ^g   Bray, Freddie ^h   Baumann, Michael ⁱ   Vikram, Bhadrasain ^j   Hanna, Timothy P ^g,k   Knaul, Felicia M ^b,c   Lievens, Yolande ^l,m   Lui, Tracey Y M ^e   Milosevic, Michael ^d   O'Sullivan, Brian ^d,f   Rodin, Danielle L ^f   Rosenblatt, Eduardo ⁿ   Van Dyk, Jacob ^o   Yap, Mei Ling ^g   Zubizarreta, Eduardo ^p   Gospodarowicz, Mary ^d,f  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

ⁱ UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^j NATIONAL CANCER INSTITUTE   (United States)

^k QUEEN S UNIVERSITY   (Canada)

^l GHENT UNIVERSITY HOSPITAL   (Belgium)

^m GHENT UNIVERSITY   (Belgium)

ⁿ INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

^o UNIVERSITY OF WESTERN ONTARIO   (Canada)

^p Global Task Force on Radiotherapy for Cancer Control   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; COST BENEFIT ANALYSIS; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; INVESTMENT; LOWEST INCOME GROUP; MEDICAL EDUCATION; MEDICAL SERVICE; MEDICAL SOCIETY; MIDDLE INCOME COUNTRY; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; REVIEW; SOCIOECONOMICS; DEVELOPING COUNTRY; ECONOMICS; FORECASTING; HEALTH; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; MASS COMMUNICATION; MORTALITY; NEOPLASMS; PUBLIC HEALTH; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; TRENDS;

COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; DIFFUSION OF INNOVATION; FORECASTING; GLOBAL HEALTH; HEALTH CARE COSTS; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; MODELS, ECONOMIC; NATIONAL HEALTH PROGRAMS; NEOPLASMS; RADIOTHERAPY; SOCIOECONOMIC FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84942115373     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)00222-3     Document Type: Review

References (190)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015, 136:E359-E386.
2. Bray F, Jemal A, Grey N, Ferlay J, Forman D Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012, 13:790-801.
3. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
4. Bloom DE, Cafiero ET, Jané-Llopis E, et al. The global economic burden of non-communicable diseases 2011, World Economic Forum, Geneva.
5. Gunderson LLT, Joel E Clinical Radiation Oncology 2011, Elsevier, Philadelphia, PA. 3rd edn.
6. Barton MB, Jacob S, Shafiq J, et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol 2014, 112:140-144.
7. Zubizarreta EH, Fidarova E, Healy B, Rosenblatt E Need for radiotherapy in low and middle income countries-the silent crisis continues. Clin Oncol (R Coll Radiol) 2015, 27:107-114.
8. Political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases, A/66/L.1 UN, (accessed April 20, 2014). http://www.un.org/ga/search/view_doc.asp?symbol=A/66/L.1.
9. 65th World Health Assembly. WHA65(8) Prevention and control of noncommunicable diseases: follow-up to the high-level meeting of the United Nations General Assembly on the prevention and control of non-communicable diseases WHO, (accessed Jan 15, 2012). http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_DIV3-en.pdf.
10. Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases 2013, WHO, World Health Organization, Geneva.
11. NCD global monitoring framework WHO, (accessed July 5, 2015). http://www.who.int/nmh/global_monitoring_framework/en/.
12. Atun R Decisive action to end apathy and achieve 25×25 NCD targets. Lancet 2014, 384:384-385.
13. Wild CP, Bray F, Forman D, Franceschi S, Sankaranarayanan R, Straif K Cancer in the 25×25 non-communicable disease targets. Lancet 2014, 384:1502-1503.
14. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010, 376:1186-1193.
15. Zietman A Bringing radiation therapy to underserved nations: an increasingly global responsibility in an ever-shrinking world. Int J Radiat Oncol Biol Phys 2014, 89:440-442.
16. WHA67.22-Access to essential medicines. WHA Resolution: Sixty-seventh World Health Assembly WHO, (accessed July 30, 2015). https://apps.who.int/medicines/en/Js21453en/.
17. Surgery: the neglected component of primary care WHO, (accessed July 30, 2015). http://www.who.int/surgery/esc_component/en/.
18. Burki TK WHO resolution on access to palliative care. Lancet Oncol 2014, 15:e109.
19. Rosenblatt E, Fidarova E Human Health Series No IAEA 30. Implementation of high dose rate brachytherapy in limited resource settings 2015, International Atomic Energy Agency, Vienna.
20. Einck JP, Hudson A, Shulman AC, et al. Implementation of a high-dose-rate brachytherapy program for carcinoma of the cervix in Senegal: a pragmatic model for the developing world. Int J Radiat Oncol Biol Phys 2014, 89:462-467.
21. Kigula-Mugambe JB, Durosinmi-Etti FA Radiotherapy in cancer management at Mulago Hospital, Kampala, Uganda. East Afr Med J 1996, 73:611-613.
22. Chowdhury AM, Bhuiya A, Chowdhury ME, Rasheed S, Hussain Z, Chen LC The Bangladesh paradox: exceptional health achievement despite economic poverty. Lancet 2013, 382:1734-1745.
23. Jamison DT, Summers LH, Alleyne G, et al. Global health 2035: a world converging within a generation. Lancet 2013, 382:1898-1955.
24. Meara JG, Leather AJM, Hagander L, et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet 2015, 386:569-624.
25. Sustainable development, the Future We Want, UN General Assembly Resolution, A/66/L.56, para 138-141 UN, (accessed July 5, 2015). http://www.uncsd2012.org/content/documents/814UNCSD%20REPORT%20final%20revs.pdf.
26. Crossing the quality chasm. A new health system for the 21st century 2001, Institute of Medicine, National Academies Press, Washington, DC.
27. Peters LJ, O'Sullivan B, Giralt J, et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J Clin Oncol 2010, 28:2996-3001.
28. Abrams RA, Winter KA, Regine WF, et al. Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704-a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 2012, 82:809-816.
29. USAID ASSIST Institute of Medicine workshop on quality of health care in low- and middle-income countries (accessed July 28, 2015). https://www.usaidassist.org/content/institute-medicine-workshop-quality-health-care-low-and-middle-income-countries.
30. The rise of the south: human progress in a diverse world 2013, UN Development Programme, United Nations, New York.
31. Jemal A The cancer atlas 2015, American Cancer Society, Atlanta. 2nd edn.
32. Gersten OWJ The cancer transition in Japan since 1951. Demogr Res 2002, 7:271-306.
33. Bray F Transitions in human development and the global cancer burden. World cancer report 2014 2014, 54-68. International Agency for Research on Cancer, Lyon. C.P. Wild, B. Stewart (Eds.).
34. Wabinga HR, Nambooze S, Amulen PM, Okello C, Mbus L, Parkin DM Trends in the incidence of cancer in Kampala, Uganda 1991-2010. Int J Cancer 2014, 135:432-439.
35. Forman DBF, Brewster DH, Gombe Mbalawa C, et al. Cancer incidence in continents volume 5 2014, International Agency for Research on Cancer, Lyon.
36. Chokunonga E, Borok MZ, Chirenje ZM, Nyakabau AM, Parkin DM Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010. Int J Cancer 2013, 133:721-729.
37. Bray F, Lortet-Tieulent J, Znaor A, Brotons M, Poljak M, Arbyn M Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia. Vaccine 2013, 31(suppl 7):H32-H45.
38. Delaney G, Jacob S, Featherstone C, Barton M The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 2005, 104:1129-1137.
39. Borras JM, Barton M, Grau C, et al. The impact of cancer incidence and stage on optimal utilization of radiotherapy: methodology of a population based analysis by the ESTRO-HERO project. Radiother Oncol 2015, published online May 19. 10.1016/j.radonc.2015.04.021.
40. Borras JM, Lievens Y, Dunscombe P, et al. The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis. Radiother Oncol 2015, published online May 14. 10.1016/j.radonc.2015.04.018.
41. Mackillop WJ, Kong W, Brundage M, et al. A comparison of evidence-based estimates and empirical benchmarks of the appropriate rate of use of radiation therapy in Ontario. Int J Radiat Oncol Biol Phys 2015, 91:1099-1107.
42. Kerba M, Miao Q, Zhang-Salomons J, Mackillop W Defining the need for breast cancer radiotherapy in the general population: a criterion-based benchmarking approach. Clin Oncol (R Coll Radiol) 2007, 19:481-489.
43. Asli LM, Kvaløy SO, Jetne V, et al. Utilization of radiation therapy in Norway after the implementation of the national cancer plan-a national, population-based study. Int J Radiat Oncol Biol Phys 2014, 90:707-714.
44. Wong K Estimation of the optimal number of radiotherapy fractions for cancer patients: a review of the evidence 2012, University of New South Wales, Sydney.
45. Slotman BJ, Cottier B, Bentzen SM, Heeren G, Lievens Y, van den Bogaert W Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1. Radiother Oncol 2005, 75:349-354.
46. Planning national radiotherapy services: a practical tool. IAEA Human Health Series 14. IAEA International Atomic Energy Agency, (accessed June 22, 2015). http://www-pub.iaea.org/MTCD/Publications/PDF/Pub1462_web.pdf.
47. Setting up a radiotherapy programme: clinical, medical physics, radiation protection and safety aspects 2008, International Atomic Energy Agency, International Atomic Energy Agency, Vienna.
48. Datta NR, Samiei M, Bodis S Radiotherapy infrastructure and human resources in Europe-present status and its implications for 2020. Eur J Cancer 2014, 50:2735-2743.
49. Rosenblatt E, Izewska J, Anacak Y, et al. Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database. Lancet Oncol 2013, 14:e79-e86.
50. Dunscombe P, Grau C, Defourny N, et al. Guidelines for equipment and staffing of radiotherapy facilities in the European countries: final results of the ESTRO-HERO survey. Radiother Oncol 2014, 112:165-177. the HERO Consortium.
51. Lievens Y, van den Bogaert W, Kesteloot K Activity-based costing: a practical model for cost calculation in radiotherapy. Int J Radiat Oncol Biol Phys 2003, 57:522-535.
52. Lievens Y, Defourny N, Coffey M, et al. Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol 2014, 112:178-186. the HERO Consortium.
53. DIRAC (Directory of radiotherapy centres) International Atomic Energy Agency, (accessed Nov 14, 2014). http://nucleus.iaea.org/HHW/m/DBStatistics/DIRAC/.
54. Grover S, Xu MJ, Yeager A, et al. A systematic review of radiotherapy capacity in low- and middle-income countries. Front Oncol 2014, 4:380.
55. Gillan C, Briggs K, Goytisolo Pazos A, et al. Barriers to accessing radiation therapy in Canada: a systematic review. Radiat Oncol 2012, 7:167.
56. Planning for the best: tripartite national strategic plan for radiation oncology 2012-2022, version 1. Australia Radiation Oncology Tripartite Committee, (accessed July 13, 2015). http://www.radiationoncology.com.au/supporting-docs/PlanningForTheBest-TripartiteNationalStrategicPlanForRadiationOncology.2012-2022.pdf.
57. Achieving a world-class radiotherapy service across the UK Cancer Research UK, (accessed July 13, 2015). http://www.cancerresearchuk.org/prod_consump/groups/cr_common/@nre/@pol/documents/generalcontent/crukmig_1000ast-3360.pdf.
58. Abdel-Wahab M, Bourque JM, Pynda Y, et al. Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis. Lancet Oncol 2013, 14:e168-e175.
59. Datta NR, Samiei M, Bodis S Radiation therapy infrastructure and human resources in low- and middle-income countries: present status and projections for 2020. Int J Radiat Oncol Biol Phys 2014, 89:448-457.
60. Moraes FY, Marta GN, Hanna SA, et al. Brazil's Challenges and Opportunities. Int J Radiat Oncol Biol Phys 2015, 92:707-712.
61. Smigielska M, Milecki P Investment in radiotherapy infrastructure positively affected the economic status of an oncology hospital. Rep Pract Oncol Radiother 2012, 17:151-156.
62. Shulman LN, Mpunga T, Tapela N, Wagner CM, Fadelu T, Binagwaho A Bringing cancer care to the poor: experiences from Rwanda. Nat Rev Cancer 2014, 14:815-821.
63. Samiei M Challenges of making radiotherapy accessible in developing countries (accessed July 10, 2015). http://globalhealthdynamics.co.uk/cc2013/wp-content/uploads/2013/04/83-96-Samiei-varian-tpage-incld-T-page_2012.pdf.
64. Lee AW, Sze H, Lam KO, Chen X A tale of two cities in China: Hong Kong and Shenzhen. Int J Radiat Oncol Biol Phys 2014, 89:704-708.
65. Peng G, Wang T, Yang KY, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol 2012, 104:286-293.
66. Radiotherapy facilities: master planning and concept design considerations International Atomic Energy Agency, (accessed May 5, 2015). http://www-pub.iaea.org/MTCD/Publications/PDF/Pub1645web-46536742.pdf.
67. Mills EJ, Kanters S, Hagopian A, et al. The financial cost of doctors emigrating from sub-Saharan Africa: human capital analysis. BMJ 2011, 343:d7031.
68. Nwankwo KC, Dawotola DA, Sharma V Radiotherapy in Nigeria: current status and future challenges. West Afr J Radiol 2013, 20:84-88.
69. Kumar RV, Bhasker S Is the fast-paced technological advancement in radiation treatment equipment good for Indian scenario? No. J Cancer Policy 2015, 4:26-30.
70. Mostert S, Njuguna F, Langat SC, et al. Two overlooked contributors to abandonment of childhood cancer treatment in Kenya: parents' social network and experiences with hospital retention policies. Psychooncology 2014, 23:700-707.
71. Kishore J, Ahmad I, Kaur R, Mohanta PK Beliefs and perceptions about cancers among patients attending radiotherapy OPD in Delhi, India. Asian Pac J Cancer Prev 2008, 9:155-158.
72. Halkett GK, Kristjanson LJ, Lobb EA 'If we get too close to your bones they'll go brittle': women's initial fears about radiotherapy for early breast cancer. Psychooncology 2008, 17:877-884.
73. Bernier J, Hall EJ, Giaccia A Radiation oncology: a century of achievements. Nat Rev Cancer 2004, 4:737-747.
74. Thariat J, Hannoun-Levi JM, Sun Myint A, Vuong T, Gérard JP Past, present, and future of radiotherapy for the benefit of patients. Nat Rev Clin Oncol 2013, 10:52-60.
75. Bortfeld T IMRT: a review and preview. Phys Med Biol 2006, 51:R363-R379.
76. Jaffray D, Kupelian P, Djemil T, Macklis RM Review of image-guided radiation therapy. Expert Rev Anticancer Ther 2007, 7:89-103.
77. Barton MB, Frommer M, Shafiq J Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol 2006, 7:584-595.
78. Ferlay JSI, Ervik M, Dikshit R, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide 2013, International Agency for Research on Cancer, Lyon.
79. Barton MB, Jacob S, Wong KHW Review of optimal radiotherapy utilisation rates. Collaboration for Cancer Outcomes Research and Evaluation (accessed June 2, 2015). http://inghaminstitute.org.au/sites/default/files/RTU_Review_Final_v3_02042013.pdf.
80. Barton MB, Hudson HM, Delaney G, Gruver P, Liu Z Patterns of retreatment by radiotherapy. Clin Oncol (R Coll Radiol) 2011, 23:10-18.
81. Hanna TP, Shafiq J, Delaney GP, Barton MB The population benefit of radiotherapy for cervical cancer: local control and survival estimates for optimally utilized radiotherapy and chemoradiation. Radiother Oncol 2015, 114:389-394.
82. Bese NS, Kiel K, El-Gueddari B-K, Campbell OB, Awuah B, Vikram B Radiotherapy for breast cancer in countries with limited resources: program implementation and evidence-based recommendations. Breast J 2006, 12(suppl 1):S96-102. the International Atomic Energy Agency.
83. Portenoy RK Treatment of cancer pain. Lancet 2011, 377:2236-2247.
84. Cury FL, Shenouda G Palliative radiotherapy. Experimental and clinical metastasis: a comprehensive review 2013, 351-379. Springer, New York. J.V.B. Burnier, N. Miguel (Eds.).
85. MacPherson M, Montgomery L, Fox G, et al. On-line rapid palliation using helical tomotherapy: a prospective feasibility study. Radiother Oncol 2008, 87:116-118.
86. Wong RK, Letourneau D, Varma A, et al. A one-step cone-beam CT-enabled planning-to-treatment model for palliative radiotherapy-from development to implementation. Int J Radiat Oncol Biol Phys 2012, 84:834-840.
87. Rosenblatt E International Atomic Energy Agency syllabus for the education and training of radiation oncologists 2009, International Atomic Energy Agency, Vienna.
88. Eriksen JG, Beavis AW, Coffey MA, et al. The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology. Radiother Oncol 2012, 103:103-108.
89. Roles and responsbilities, and education and training requirements for clinically qualified medical physicists 2013, International Atomic Energy Agency, International Atomic Energy Agency, Vienna.
90. a syllabus for the education and training of RTTs (radiation therapists/therapy radiographers) 2005, International Atomic Energy Agency, International Atomic Energy Agency, Vienna.
91. Staffing and cost calculation International Atomic Energy Agency, (accessed March 14, 2014). http://nucleus.iaea.org/HHW/RadiationOncology/Makingthecaseforradiotherapyinyourcountry/Roleofradiotherapyincancercare/Radiotherapyisacosteffectivesystemwhichneedsabalance/index.html.
92. International construction cost survey Gardiner & Theobald, (accessed March 14, 2014). http://www.gardiner.com/assets/files/files/a47a4dcd5d29f0071e00bf2d6c589851ed552cc7/ICCS%202011%20$%20Version.pdf.
93. International construction costs: a change of pace EC Harris Research, (accessed March 14, 2014). http://www.echarris.com/pdf/8633_international%20cost%20construction%20report%20final2.pdf.
94. Healy B, Zubizarreta E Staffing in radiotherapy: an activity based approach 2014, International Atomic Energy Agency, Vienna.
95. Country and lending groups World Bank, (accessed July 1, 2015). http://data.worldbank.org/about/country-and-lending-groups.
96. Van de Werf E, Verstraete J, Lievens Y The cost of radiotherapy in a decade of technology evolution. Radiother Oncol 2012, 102:148-153.
97. Lievens Y, Grau C Health economics in radiation oncology: introducing the ESTRO HERO project. Radiother Oncol 2012, 103:109-112.
98. Grau C, Defourny N, Malicki J, et al. Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol 2014, 112:155-164. the HERO consortium.
99. Resch S, Korenromp E, Stover J, et al. Economic returns to investment in AIDS treatment in low and middle income countries. PLoS One 2011, 6:e25310.
100. Schwartländer B, Stover J, Hallett T, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 2011, 377:2031-2041. the Investment Framework Study Group.
101. The Global Fund Strategy 2012-16 Global Fund, (accessed June 30, 2015). http://www.theglobalfund.org/en/about/strategy/.
102. Stenberg K, Axelson H, Sheehan P, et al. Advancing social and economic development by investing in women's and children's health: a new Global Investment Framework. Lancet 2014, 383:1333-1354. the Study Group for the Global Investment Framework for Women's Children's Health.
103. Jaffray DA, Gospodarowicz MK Radiation therapy for cancer (accessed May 5, 2015). http://www.dcp-3.org/sites/default/files/chapters/CANCER%20ch14%20Radiation%20Therapy.pdf.
104. Making choices in health: WHO guide to cost-effectiveness analysis WHO, (accessed Aug 23, 2015). http://www.who.int/choice/publications/p_2003_generalised_cea.pdf.
105. Najjar H, Easson A Age at diagnosis of breast cancer in Arab nations. Int J Surg 2010, 8:448-452.
106. Harford JB Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all. Lancet Oncol 2011, 12:306-312.
107. Hossain MS, Iqbal MS, Khan MA, et al. Diagnosed hematological malignancies in Bangladesh-a retrospective analysis of over 5000 cases from 10 specialized hospitals. BMC Cancer 2014, 14:438.
108. Joshi P, Dutta S, Chaturvedi P, Nair S Head and neck cancers in developing countries. Rambam Maimonides Med J 2014, 5:e0009.
109. Shillcutt SD, Walker DG, Goodman CA, Mills AJ Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules. Pharmacoeconomics 2009, 27:903-917.
110. Macroeconomics and health: investing in health for economic development. Report of the Commission on Macroeconomics and Health 2001, Commission on Macroeconomics and Health, World Health Organization, Geneva.
111. Norton WE, McCannon CJ, Schall MW, Mittman BS A stakeholder-driven agenda for advancing the science and practice of scale-up and spread in health. Implement Sci 2012, 7:118.
112. Meara JG, Greenberg SL The Lancet Commission on Global Surgery global surgery 2030: evidence and solutions for achieving health, welfare and economic development. Surgery 2015, 157:834-835.
113. Okungu V, Gilson L ". . .still waiting for chloroquine": the challenge of communicating changes in first-line treatment policy for uncomplicated malaria in a remote Kenyan district. Malar J 2014, 13:258.
114. Li KMF, Rodin D, Wong K-H, Yeung R, Chow E Palliative radiotherapy. The art and science of palliative medicine 2014, 556-568. AME Publishing Company, Hong Kong. H.S.P.J. Smith (Ed.).
115. Sharma V, Gaye PM, Wahab SA, et al. Patterns of practice of palliative radiotherapy in Africa, part 1: bone and brain metastases. Int J Radiat Oncol Biol Phys 2008, 70:1195-1201.
116. Bonastre J, Noël E, Chevalier J, et al. Implications of learning effects for hospital costs of new health technologies: the case of intensity modulated radiation therapy. Int J Technol Assess Health Care 2007, 23:248-254. the STIC IMRT 2002 Investigators.
117. Wang Q, Fu AZ, Brenner S, Kalmus O, Banda HT, De Allegri M Out-of-pocket expenditure on chronic non-communicable diseases in sub-Saharan Africa: the case of rural Malawi. PLoS One 2015, 10:e0116897.
118. Antonino PHD Brazilian industrial health complex: availability of access, industrial development, and innovation policy 2013, World Health Organization, Geneva.
119. Da Silva JB, Magalhaes HM Initiatives in cancer control from Brazil's Ministry of Health. Lancet Oncol 2013, 14:385-386.
120. Yamey G What are the barriers to scaling up health interventions in low and middle income countries? A qualitative study of academic leaders in implementation science. Global Health 2012, 8:11.
121. Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011, 378:1461-1484.
122. Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010, 11:165-173.
123. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008, 26:5802-5812. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration.
124. Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC Human papillomavirus and cervical cancer. Lancet 2013, 382:889-899.
125. Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer 2003, 106:896-904.
126. Berkman A, Garcia J, Muñoz-Laboy M, Paiva V, Parker R A critical analysis of the Brazilian response to HIV/AIDS: lessons learned for controlling and mitigating the epidemic in developing countries. Am J Public Health 2005, 95:1162-1172.
127. Jit M, Brisson M, Portnoy A, Hutubessy R Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. Lancet Glob Health 2014, 2:e406-e414.
128. Yamin AE, Boulanger VM, Falb KL, Shuma J, Leaning J Costs of inaction on maternal mortality: qualitative evidence of the impacts of maternal deaths on living children in Tanzania. PLoS One 2013, 8:e71674.
129. Human resources needed for cancer control in low & middle income countries National Cancer Institute Radiation Research Program, (accessed July 5, 2015). http://rrp.cancer.gov/programsResources/human_resources_needed.htm.
130. Sullivan T, Dobrow M, Thompson L, Hudson A Reconstructing cancer services in Ontario. Healthc Pap 2004, 5:69-80. discussion 96-99.
131. Hayter CR, Payne D, Ege GN Radiation oncology in Canada 1895-1995. Int J Radiat Oncol Biol Phys 1996, 36:487-496.
132. Mackillop WJ, Bates JH, O'Sullivan B, Withers HR The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys 1996, 34:243-250.
133. Mackillop WJ Killing time: the consequences of delays in radiotherapy. Radiother Oncol 2007, 84:1-4.
134. Mackillop WJ, Groome PA, Zhang-Solomons J, et al. Does a centralized radiotherapy system provide adequate access to care?. J Clin Oncol 1997, 15:1261-1271.
135. Daly RUS. Cities to treat Ontario's cancer victims. The Toronto Star (Toronto), Jan 22, 1991.
136. The Ontario cancer plan 2005-2008 Cancer Care Ontario, Action Cancer OntarioAction Cancer Ontario, (accessed June 23, 2015). https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=34910.
137. The Ontario cancer plan 2008-2011 Cancer Care Ontario, Action Cancer OntarioAction Cancer Ontario, (accessed July 6, 2015). https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=13808.
138. The Ontario cancer plan 2011-15 Cancer Care Ontario, (accessed July 6, 2015). https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=84204.
139. The Ontario cancer plan 2015-2019 Cancer Care Ontario, (accessed July 6, 2015). https://cancercare.on.ca/common/pages/UserFile.aspx?fileId=333871.
140. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011, 377:127-138. the ICBP Module 1 Working Group.
141. Krzyzanowska MK, Blayney DW, Bosserman LD, Sullivan TJ Models that work: incorporating quality principles in different clinical settings. J Oncol Pract 2013, 9:135-137.
142. Sullivan T Improving quality and performance in Ontario's cancer services: lessons for constructing a learning healthcare system. Healthc Q 2015, 17:5-9.
143. The world factbook-2014 Central Intelligence Agency, (accessed May 5, 2015). https://www.cia.gov/library/publications/the-world-factbook/.
144. Pramesh CS, Badwe RA, Borthakur BB, et al. Delivery of affordable and equitable cancer care in India. Lancet Oncol 2014, 15:e223-e233.
145. Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol 2014, 15:489-538.
146. Lyerly HK, Fawzy MR, Aziz Z, et al. Regional variation in identified cancer care needs of early-career oncologists in China, India, and Pakistan. Oncologist 2015, 20:532-538.
147. Eleventh Five Year Plan (2007-2012)-Inclusive growth Planning Commission, Government of IndiaGovernment of India, (accessed Aug 24, 2015). http://planningcommission.nic.in/plans/planrel/fiveyr/11th/11_v3/11th_vol3.pdf.
148. Banerjee S, Mahantshetty U, Shrivastava S Brachytherapy in India-a long road ahead. J Contemp Brachytherapy 2014, 6:331-335.
149. Dinshaw KA Addressing the cancer agenda: how have we measured up? (accessed June 26, 2015). http://mohfw.nic.in/WriteReadData/l892s/Addressing%20The%20Cancer%20Agenda-How%20Have%20We%20Measured%20Up.pdf.
150. Atun R, de Andrade LO, Almeida G, et al. Health-system reform and universal health coverage in Latin America. Lancet 2015, 385:1230-1247.
151. Monteiro de Andrade L, Filho AP, Solar O, et al. Social determinants of health, universal health coverage, and sustainable development: case studies from Latin American countries. Lancet 2015, 385:1343-1351.
152. Cotlear D, Gómez-Dantés O, Knaul F, et al. Overcoming social segregation in health care in Latin America. Lancet 2015, 385:1248-1259.
153. Institui o Plano de Expansão da Radioterapia no Sistema Único de Saúde (SUS) Ministério da Saúde, (accessed July 7, 2015). http://bvsms.saude.gov.br/bvs/saudelegis/gm/2012/prt0931_10_05_2012.html.
154. Implementação de 80 soluções de radioterapia, compreendendo equipamentos, projetos básico e executivo, apoio técnico ao acompanhamento e fiscalização de obras Ministério da Saúde, (accessed July 7, 2015). http://comprasnet.gov.br/ConsultaLicitacoes/Download/Download.asp?coduasg=250005&numprp=112013&modprp=5&bidbird=N.
155. Workshop para Soluções em Formação de Recursos Humanos para Radioterapia Ministério da Saúde, (accessed July 7, 2015). http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/secretarias/911-sas-raiz/daet-raiz/doencas-cronica/doencas-cronicas-banner/15218-banner-workshop.
156. Globocan 2012, Bangladesh estimated cancer incidence, all ages: both sexes International Agency for Research on Cancer, (accessed July 4, 2015). http://globocan.iarc.fr/old/summary_table_pop-html.asp?selection=14050&title=Bangladesh&sex=0&type=0&window=1&sort=0&submit=%C2%A0Execute.
157. Hussain SA, Sullivan R Cancer control in Bangladesh. Jpn J Clin Oncol 2013, 43:1159-1169.
158. Wold Bank Development Indicators. Zimbabwe World Bank, (accessed July 4, 2015). http://data.worldbank.org/country/zimbabwe.
159. Chokunonga EBM, Nyakabau AM Zimbabwe National Cancer Registry, 2012 annual report Makunike-Mutasa, (accessed June 1, 2015). http://afcrn.org/attachments/article/83/ZNCR%20%202011%20Annual%20Report.pdf.
160. Stjernswärd J National training of radiotherapists in Sri Lanka and Zimbabwe: priorities and strategies for cancer control in developing countries. Int J Radiat Oncol Biol Phys 1990, 19:1275-1278.
161. McCoy D, Bennett S, Witter S, et al. Salaries and incomes of health workers in sub-Saharan Africa. Lancet 2008, 371:675-681.
162. Al-Shorbaji N, Atun R, Car J, Majeed A, Wheeler E eLearning for undergraduate health professional education: a systematic review informing a radical transformation of health workforce development (accessed July 5, 2015). http://www.who.int/hrh/documents/14126-eLearningReport.pdf.
163. Coleman CN, Formenti SC, Williams TR, et al. The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries. Front Oncol 2014, 4:333.
164. Coleman CN Bringing cancer care to the underserved globally: a challenging problem for which radiation oncology can pioneer novel solutions. Int J Radiat Oncol Biol Phys 2014, 89:443-445. on behalf of many others.
165. Sharpe MB, Moore KL, Orton CG Point/Counterpoint: Within the next ten years treatment planning will become fully automated without the need for human intervention. Med Phys 2014, 41:120601.
166. Datta NR, Heuser M, Samiei M, Shah R, Lutters G, Bodis S Teleradiotherapy network: applications and feasibility for providing cost-effective comprehensive radiotherapy care in low- and middle-income group countries for cancer patients. Telemed J E Health 2015, 21:523-532.
167. Dimaras H, Dimba EA, Gallie BL Challenging the global retinoblastoma survival disparity through a collaborative research effort. Br J Ophthalmol 2010, 94:1415-1416.
168. Gallie BL, Zhao J, Vandezande K, White A, Chan HS Global issues and opportunities for optimized retinoblastoma care. Pediatr Blood Cancer 2007, 49(suppl):1083-1090.
169. Ribeiro RC Improving survival of children with cancer worldwide: the St Jude International Outreach Program approach. Stud Health Technol Inform 2012, 172:9-13.
170. Global economic prospects World Bank, (accessed July 5, 2015). http://www.worldbank.org/en/publication/global-economic-prospects.
171. Harnessing natural resources for sustainable development: challenges and solutions UN Sustainable Development Solutions Network, (accessed May 26, 2015). http://unsdsn.org/wp-content/uploads/2014/02/TG10-Final-Report.pdf.
172. Atun R, Knaul FM, Akachi Y, Frenk J Innovative financing for health: what is truly innovative?. Lancet 2012, 380:2044-2049.
173. World Bank Guarantee Program-for the consultation of "modernizing the World Bank's operational policy on guarantees World Bank, (accessed July 5, 2015). http://siteresources.worldbank.org/INTGUARANTEES/Resources/HighlightsWBGProgramforConsulJan252012.pdf.
174. The World Bank Group guarantee products World Bank, (accessed July 5, 2015). http://treasury.worldbank.org/bdm/pdf/Brochures/WBG_Guarantees_Matrix.pdf.
175. Ketkar SL, Ratha D Development finance via diaspora bonds track record and potential: policy research working papers (accessed May 26, 2015). http://elibrary.worldbank.org/doi/book/10.1596/1813-9450-4311.
176. Peterborough social impact bond: one year on Social Finance UK, (accessed July 4, 2015). http://www.socialfinance.org.uk/peterborough-social-impact-bond-one-year-on/.
177. High-level meeting on non-communicable diseases UN, (accessed July 5, 2015). http://www.un.org/en/ga/president/65/issues/ncdiseases.shtml.
178. Resolution adopted by the General Assembly on 13 May 2010. 64/265. Prevention and control of non-communicable diseases UN, (accessed July 5, 2015). http://www.un.org/en/ga/search/view_doc.asp?symbol=A/RES/64/265&Lang=E.
179. Global action plan for the prevention and control of NCDs 2013-2020 WHO, (accessed July 5, 2015). http://www.who.int/nmh/events/ncd_action_plan/en/.
180. The global economic burden of non-communicable diseases World Economic Forum, (accessed July 5, 2015). http://www.weforum.org/reports/global-economic-burden-non-communicable-diseases.
181. Global health and foreign policy UN, (accessed July 5, 2015). http://www.un.org/ga/search/view_doc.asp?symbol=A/67/L.36&referer=http://www.un.org/en/ga/info/draft/index.shtml&Lang=E.
182. Global status report on noncommunicable diseases WHO, (accessed July 5, 2015). http://www.who.int/nmh/publications/ncd-status-report-2014/en/.
183. Noncommunicable diseases country profiles WHO, (accessed July 5, 2015). http://www.who.int/nmh/publications/ncd-profiles-2014/en/.
184. Sloan FG Hellen. Cancer control opportunities in low- and middle-income countries. Institute of Medicine (US) Committee on Cancer Control in Low- and Middle-Income Countries 2007, National Academies Press, Washington, DC.
185. IAEA Human Health Reports. Inequity in cancer care: a global perspective 2011, International Atomic Energy Agency, International Atomic Energy Agency, Vienna.
186. World cancer declaration Union for International Cancer Control, (accessed July 5, 2015). http://www.uicc.org/world-cancer-declaration.
187. Declaration of commitment on HIV/AIDS. "Global Crisis-Global Action." UN, (accessed July 5, 2015). http://www.un.org/ga/aids/coverage/FinalDeclarationHIVAIDS.html.
188. Are C, Rajaram S, Are M, et al. A review of global cancer burden: trends, challenges, strategies, and a role for surgeons. J Surg Oncol 2013, 107:221-226.
189. Agenda item 15.5- Strengthening of pallative care as a component of comprehensive care throughout the life course: Hearing before the Sixty-Seventh World Health Assembly (accessed July 5, 2015). http://hospicecare.com/uploads/2014/12/WHA%20Palliative%20Care%20Resolution.pdf.
190. Knaul FM, Farmer PE, Bhadelia A, Berman P, Horton R Closing the divide: the Harvard Global Equity Initiative- Lancet Commission on global access to pain control and palliative care. Lancet 2015, published online March 8. http://dx.doi.org/10.1016/S0140-6736(15)60289-6.